Medindia LOGIN REGISTER
Medindia
Advertisement

Substance Abuse, Addiction, and Treatment: Global Markets

Monday, September 11, 2017 General News
Advertisement
NEW YORK, Sept. 11, 2017 /PRNewswire/ -- The global substance abuse and addiction treatment market reached $3.1 billion in 2016 and should reach nearly $4.4 billion in 2021, at a compound annual growth rate (CAGR) of 7.0%.Read the full report: https://www.reportlinker.com/p05096299• The drug abuse segment reached nearly $2.3 billion in 2016 and should reach $3.1 billion by 2021, at a CAGR of 6.8%.• Nicotine abuse segment reached $758 million in 2016 and should reach nearly $1.1 billion by 2021, at a CAGR of 7.3%.Chapter 1: IntroductionThe factors fueling the growth of the substance abuse and addiction treatment market are the:• Rising incidence of drug and alcohol abuse.• Growing awareness of substance abuse among employers.• Increasing number of accidents caused by driving under the influence (DUIs).• Rising aging population leading to increased alcohol use, along with increased funding by the government and nongovernmental organizations.Moreover, the formulation of stringent laws across various geographies and growing awareness in developing regions regarding the dangers of substance abuse are key factors in the expansion of the market for drug and alcohol addiction treatment. In 2014, Brazil's federal government passed a law that made it mandatory for professional drivers to pass a hair follicle drug test in order to apply for license renewal; this law, in turn, generates revenue for the substance abuse, addiction and treatment markets. The association of tobacco use, drugs and alcohol with modern lifestyles in social and entertainment platforms may encourage substance abuse and addiction. The growing population base affected with the drug addiction along with rising health concerns due to drug abuse has led to the emergence of technically advanced and more sensitive drug tests and treatments, as well as more accurate drug screening devices, present growth opportunities for the providers in this market. But the limited effectiveness of the available treatment drugs is the key challenge facing industry stakeholders.The substance abuse and addiction treatment market is segmented into the condition, treatment type, and geography. Conditions are further segmented into groups such as nicotine use, alcohol and drug abuse. The drug abuse subsegment is further categorized into opioid and cocaine abuse. The treatment market is segmented into Chantix, Zyban, detoxification, Campral, Antabuse, Dolophine (methadone), Suboxone and others. Geographically, the market is segmented into North America, Europe, Asia-Pacific and the Rest of World (ROW). The key players operating in this market are Pfizer, GlaxoSmithKline, Alkermes plc, Teva Pharmaceuticals, Reckitt Benckiser Pharmaceuticals and Forest Laboratories Inc.Study Goals and Objectives• Define as well as identify the key market segments and market structure of the substance abuse and addiction treatment market.• Measure and estimate the global amount of substance abuse, addiction treatments and market segments, which include condition, treatment and geographic areas.• Identify the key market dynamics and factors impacting global substance abuse and addiction treatment market and its subsegments.• To identify the trends, gaps and opportunities in each segment of the industry.• To focus exclusively on geographic segmentation, and to analyze trends and opportunities in the primary geographic regions: North America, Europe, Asia-Pacific and the ROW.• To identify the major stakeholders, their product portfolios and recent developments, and describe the competitive landscape of the market leaders.Reasons for Doing This StudyThis research report presents an in-depth analysis of the global substance abuse and addiction treatment industry by condition or type of dependency, available treatments and geographic markets. The study includes the types of addiction requiring substance abuse and addiction treatment, and analyzes the clinical guidelines and drug testing laws within its respective regions. This investigation includes an in-depth analysis of the major companies operating in the global substance abuse and addiction treatment industry and provides a comprehensive analysis of drug abuse statistics. This report also focuses on drug testing-related trends in recent years covering different geographical regions such as the U.S., Europe and Japan. Substance abuse and addiction treatment conditions are mainly segmented into nicotine, alcohol and drug abuse. Drug abuse is further categorized into opioid or cocaine abuse. The treatment market is further segmented by pharmaceutical options such as Chantix, Zyban, Campral, Antabuse, methadone, Suboxone and other medicines or detoxification treatment choices.Scope of the ReportThis report presents an in-depth analysis of the global substance abuse and addiction treatment market by conditions, treatments, and geographic markets; it includes the principal drug abuse conditions that are incorporated into several therapeutic treatment methods. This report examines the role of supplychainmembers from manufacturers to researchers, and contains a comprehensive analysis of the dominant companies operating in the global substance abuse and addiction treatment market. The indepth patent analysis section of the report will focus extensively on the technological trends across years and geographies such as the U.S., Europe and China. This study considers the revenue generated by medications or therapeutics during the substance abuse treatment process. It does not review the expenses associated with services such as counseling, psychological therapy, rehabilitation or others. The report focuses on the substances that are either directly consumed or injected, hence the nicotine segment considers the medicines that help to treat smokeless tobacco addiction but does not take into account drugs that are only used for smoking cessation. The report examines all forms of opioids and cocaine in whichever form or mode they areingested, and considers all types of alcohol abuse.The market study is detailed for products based on applications as well as its further implication in the research and development area. These two segmentations are also discussed in depth for the given period. The market is broken down by the geographical regions of North America, Europe, Asia-Pacificand the ROW. Key market players operating in this market are Pfizer, GlaxoSmithKline, Alkermes, Teva Pharmaceuticals, Reckitt Benckiser, Forest Laboratories, and others totaling to about 20 companies.Intended AudienceThe intended audience of this report includes:• Drug screening equipment and device manufacturers and potential entrants.• The laboratories providing drug screening services to various end users.• Dealers, distributors and service providers of drug screening products and drug abuse.• Healthcare centers and rehabilitation centers providing addiction treatment.• Healthcare service providers and private research institutes.• Government authorities and public service boards.• Research institutes, associations and academia.Information Sources and MethodologyThe global substance abuse and addiction treatment market was assessed and calculated through a bottom-up approach that involved identifying the revenues by each market segment. The following process was followed to ensure quality and consistency of the estimates:• In-depth primary and secondary research was conducted.• Primary research included gathering intelligence from key market players. The participants of these interviews included CEOs, key opinion leaders, product experts and directors.• Secondary research not only included collation of data from freely available sources, but also by paid subscription from specialized industry magazines and websites.• To best assure triangulation of market estimates, the derived values were again validated through primary research.• Key factors considered during market estimations were price, volumes, incidence and prevalence rates, number of procedures, etc.• The geographic segmentation was assessed through various parameters such as the number of players in a particular region, incidence and prevalence rates, and the extent of research activity occurring in that geography and future potential.Geographic BreakdownIn this report, the geographic regions considered for market analysis include, and only include:North AmericaUnited States• Canada• MexicoEuropeGermany• France• United Kingdom• Italy• Spain• Russia• OthersAsiaAustralia• China• Japan• India• OthersRest of World (ROW):• Latin America• Middle East• AfricaRead the full report: https://www.reportlinker.com/p05096299 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. https://www.reportlinker.com  __________________________ Contact Clare: [email protected]  US: (339)-368-6001 Intl: +1 339-368-6001 

View original content:http://www.prnewswire.com/news-releases/substance-abuse-addiction-and-treatment-global-markets-300517169.html

SOURCE Reportlinker

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close